Panagora Asset Management Inc Blueprint Medicines Corp Transaction History

Panagora Asset Management Inc

  • $19.6 Billion
  • Q1 2025

A detailed history of Panagora Asset Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Panagora Asset Management Inc holds 205,582 shares of BPMC stock, worth $26.4 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
205,582
Previous 71,416 187.87%
Holding current value
$26.4 Million
Previous $6.23 Million 192.16%
% of portfolio
0.09%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$86.69 - $115.63 $11.6 Million - $15.5 Million
134,166 Added 187.87%
205,582 $18.2 Million
Q4 2024

Feb 13, 2025
SELL
$82.48 - $101.39 $2.09 Million - $2.57 Million
-25,390 Reduced 26.23%
71,416 $6.23 Million
Q3 2024

Nov 13, 2024
SELL
$84.1 - $120.5 $4.27 Million - $6.12 Million
-50,758 Reduced 34.4%
96,806 $8.95 Million
Q2 2024

Jul 29, 2024
SELL
$85.18 - $108.78 $9.87 Million - $12.6 Million
-115,910 Reduced 43.99%
147,564 $15.9 Million
Q1 2024

May 07, 2024
SELL
$73.17 - $99.79 $514,824 - $702,122
-7,036 Reduced 2.6%
263,474 $25 Million
Q4 2023

Feb 08, 2024
BUY
$43.96 - $92.84 $313,083 - $661,206
7,122 Added 2.7%
270,510 $25 Million
Q3 2023

Oct 31, 2023
SELL
$46.9 - $66.0 $277,788 - $390,918
-5,923 Reduced 2.2%
263,388 $13.2 Million
Q2 2023

Aug 11, 2023
SELL
$42.2 - $66.37 $212,266 - $333,841
-5,030 Reduced 1.83%
269,311 $17 Million
Q1 2023

May 11, 2023
BUY
$37.97 - $50.0 $1.47 Million - $1.94 Million
38,747 Added 16.45%
274,341 $12.3 Million
Q4 2022

Feb 13, 2023
BUY
$41.06 - $66.48 $1.18 Million - $1.91 Million
28,701 Added 13.87%
235,594 $10.3 Million
Q3 2022

Nov 14, 2022
BUY
$49.93 - $77.7 $1.34 Million - $2.09 Million
26,862 Added 14.92%
206,893 $13.6 Million
Q2 2022

Aug 15, 2022
SELL
$45.23 - $70.15 $24,876 - $38,582
-550 Reduced 0.3%
180,031 $9.09 Million
Q1 2022

May 12, 2022
BUY
$54.1 - $110.08 $209,204 - $425,679
3,867 Added 2.19%
180,581 $11.5 Million
Q4 2021

Feb 10, 2022
BUY
$94.25 - $115.99 $2.98 Million - $3.67 Million
31,654 Added 21.82%
176,714 $18.9 Million
Q3 2021

Nov 10, 2021
BUY
$80.98 - $109.47 $11.5 Million - $15.6 Million
142,464 Added 5487.83%
145,060 $14.9 Million
Q2 2021

Aug 11, 2021
BUY
$82.78 - $101.0 $214,896 - $262,196
2,596 New
2,596 $228,000
Q4 2019

Feb 12, 2020
SELL
$66.73 - $82.59 $2.14 Million - $2.64 Million
-32,014 Closed
0 $0
Q2 2019

Aug 09, 2019
BUY
$73.54 - $97.8 $2.35 Million - $3.13 Million
32,014 New
32,014 $3.02 Million
Q2 2018

Aug 14, 2018
SELL
$60.96 - $101.18 $42,184 - $70,016
-692 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$73.28 - $102.95 $1,758 - $2,470
-24 Reduced 3.35%
692 $63,000
Q4 2017

Feb 14, 2018
BUY
$62.91 - $88.32 $45,043 - $63,237
716
716 $54,000

Others Institutions Holding BPMC

# of Institutions
391
Shares Held
68.5M
Call Options Held
1.54M
Put Options Held
1.08M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $7.66B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email